Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro.
Xiang DX, Chen Q, Pang L, Zheng CL. Xiang DX, et al. J Virol Methods. 2011 Dec;178(1-2):137-42. doi: 10.1016/j.jviromet.2011.09.003. Epub 2011 Sep 17. J Virol Methods. 2011. PMID: 21945220
Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.
Xiang D, Zheng Y, Duan W, Li X, Yin J, Shigdar S, O'Connor ML, Marappan M, Zhao X, Miao Y, Xiang B, Zheng C. Xiang D, et al. Int J Nanomedicine. 2013;8:4103-13. doi: 10.2147/IJN.S53622. Epub 2013 Oct 30. Int J Nanomedicine. 2013. PMID: 24204140 Free PMC article.
Aptamer-guided extracellular vesicle theranostics in oncology.
Tran PH, Xiang D, Nguyen TN, Tran TT, Chen Q, Yin W, Zhang Y, Kong L, Duan A, Chen K, Sun M, Li Y, Hou Y, Zhu Y, Ma Y, Jiang G, Duan W. Tran PH, et al. Theranostics. 2020 Feb 21;10(9):3849-3866. doi: 10.7150/thno.39706. eCollection 2020. Theranostics. 2020. PMID: 32226524 Free PMC article. Review.
Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L, Xiang D, Shigdar S, Yang W, Li Q, Lin J, Liu K, Duan W. Li L, et al. Int J Nanomedicine. 2014 Feb 21;9:1083-96. doi: 10.2147/IJN.S59779. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24591829 Free PMC article.
RNA aptamers targeting cancer stem cell marker CD133.
Shigdar S, Qiao L, Zhou SF, Xiang D, Wang T, Li Y, Lim LY, Kong L, Li L, Duan W. Shigdar S, et al. Cancer Lett. 2013 Mar 1;330(1):84-95. doi: 10.1016/j.canlet.2012.11.032. Epub 2012 Nov 27. Cancer Lett. 2013. PMID: 23196060
Aptamers as theranostic agents: modifications, serum stability and functionalisation.
Shigdar S, Macdonald J, O'Connor M, Wang T, Xiang D, Al Shamaileh H, Qiao L, Wei M, Zhou SF, Zhu Y, Kong L, Bhattacharya S, Li C, Duan W. Shigdar S, et al. Sensors (Basel). 2013 Oct 10;13(10):13624-37. doi: 10.3390/s131013624. Sensors (Basel). 2013. PMID: 24152925 Free PMC article. Review.
Cancer stem cells: A contentious hypothesis now moving forward.
O'Connor ML, Xiang D, Shigdar S, Macdonald J, Li Y, Wang T, Pu C, Wang Z, Qiao L, Duan W. O'Connor ML, et al. Cancer Lett. 2014 Mar 28;344(2):180-7. doi: 10.1016/j.canlet.2013.11.012. Epub 2013 Dec 11. Cancer Lett. 2014. PMID: 24333726 Review.
Aptamer-mediated cancer gene therapy.
Xiang D, Shigdar S, Qiao G, Zhou SF, Li Y, Wei MQ, Qiao L, Shamaileh HA, Zhu Y, Zheng C, Pu C, Duan W. Xiang D, et al. Curr Gene Ther. 2015;15(2):109-19. doi: 10.2174/1566523214666141224095105. Curr Gene Ther. 2015. PMID: 25537777
Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
Xiang D, Zheng C, Zhou SF, Qiao S, Tran PH, Pu C, Li Y, Kong L, Kouzani AZ, Lin J, Liu K, Li L, Shigdar S, Duan W. Xiang D, et al. Theranostics. 2015 Jul 2;5(10):1083-97. doi: 10.7150/thno.11711. eCollection 2015. Theranostics. 2015. PMID: 26199647 Free PMC article.
EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model.
Wang T, Gantier MP, Xiang D, Bean AG, Bruce M, Zhou SF, Khasraw M, Ward A, Wang L, Wei MQ, AlShamaileh H, Chen L, She X, Lin J, Kong L, Shigdar S, Duan W. Wang T, et al. Theranostics. 2015 Oct 20;5(12):1456-72. doi: 10.7150/thno.11692. eCollection 2015. Theranostics. 2015. PMID: 26681989 Free PMC article.
52 results
Jump to page